Phase II study for bevacizumab combined with S-1 and raltitrexed in the treatment of metastatic colorectal cancer resistant to 5-fluorouracil / oxaliplatin /irinotecan
收藏NIAID Data Ecosystem2026-03-09 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2681508
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Case series:bevacizumab combined with S-1 and raltitrexed
Primary outcome(s): ORR
Study Design: Non randomized control
创建时间：
2015-09-15
